Projects receive grants as part of Biomedical Catalyst project

Grants from the government-backed Biomedical Catalyst totalling £39m have been awarded to 32 projects led by small and medium-sized businesses and universities in an effort to accelerate the development of innovative solutions to healthcare challenges.

These are the first substantial awards made from the £180m Biomedical Catalyst, a programme of public funding jointly managed by the Technology Strategy Board and the Medical Research Council (MRC).

The programme is designed to deliver effective support for the best life-science opportunities arising in the UK, enabling businesses and academics to speed up the translation of scientific ideas into commercial propositions.

A digital healthcare system that will provide the early diagnosis of dementia, a universal flu vaccine that could protect against all known strains of the illness and a targeted therapy for the treatment of prostate cancer are just three of the planned innovations that will be evaluated, developed or demonstrated using the funding provided by the Biomedical Catalyst.